d-amphetamine ( 20 mg ) was administered intravenously in a double-blind design to 17 schizophrenic patients with and without concurrent 3-week lithium carbonate pretreatment to evaluate the lithium attenuation of d-amphetamine effects which we had observed in affective disorder patients .
C0085217
lithium carbonate
C0023870
lithium